Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial
Rensel, Mary, Zabeti, Aram, Mealy, Maureen A, Cimbora, Daniel, She, Dewei, Drappa, Jorn, Katz, Eliezer
Published in Multiple sclerosis (01.05.2022)
Published in Multiple sclerosis (01.05.2022)
Get full text
Journal Article
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
Aktas, Orhan, Smith, Michael A., Rees, William A., Bennett, Jeffrey L., She, Dewei, Katz, Eliezer, Cree, Bruce A. C., Fujihara, Kazuo, Paul, Friedemann, Hartung, Hans‐Peter, Marignier, Romain, Kim, Ho Jin, Weinshenker, Brian G., Pittock, Sean J., Wingerchuk, Dean M., Cutter, Gary R., Green, Ari J., Mealy, Maureen A., Drappa, Jorn
Published in Annals of neurology (01.05.2021)
Published in Annals of neurology (01.05.2021)
Get full text
Journal Article
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets
Forsthuber, Thomas G., Cimbora, Daniel M., Ratchford, John Nolan, Katz, Eliezer, Stüve, Olaf
Published in Therapeutic Advances in Neurological Disorders (01.01.2018)
Published in Therapeutic Advances in Neurological Disorders (01.01.2018)
Get full text
Book Review
Journal Article
Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
Cree, Bruce AC, Bennett, Jeffrey L, Sheehan, Mark, Cohen, Jeffrey, Hartung, Hans-Peter, Aktas, Orhan, Kim, Ho Jin, Paul, Friedemann, Pittock, Sean, Weinshenker, Brian, Wingerchuk, Dean, Fujihara, Kazuo, Cutter, Gary, Patra, Kaushik, Flor, Armando, Barron, Gerard, Madani, Soraya, Ratchford, John N, Katz, Eliezer
Published in Multiple sclerosis (01.06.2016)
Published in Multiple sclerosis (01.06.2016)
Get full text
Journal Article
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
Marignier, Romain, Bennett, Jeffrey L, Kim, Ho Jin, Weinshenker, Brian G, Pittock, Sean J, Wingerchuk, Dean, Fujihara, Kazuko, Paul, Friedemann, Cutter, Gary R, Green, Ari J, Aktas, Orhan, Hartung, Hans-Peter, Lublin, Fred D, Williams, Ian M, Drappa, Jorn, She, Dewei, Cimbora, Daniel, Rees, William, Smith, Michael, Ratchford, John N, Katz, Eliezer, Cree, Bruce A C
Published in Neurology : neuroimmunology & neuroinflammation (01.05.2021)
Published in Neurology : neuroimmunology & neuroinflammation (01.05.2021)
Get full text
Journal Article
YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study1,2,3
Osama Gaber, A., Mulgaonkar, Shamkant, Kahan, Barry D., Steve Woodle, E., Alloway, Rita, Bajjoka, Iman, Jensik, Stephen, Klintmalm, Goran B., Patton, Pamela R., Wiseman, Alexander, Lipshutz, Gerald, Kupiec‐Weglinski, Jerzy, Gaber, Lilian W., Katz, Eliezer, Irish, William, Squiers, Elizabeth C., Hemmerich, Stefan
Published in Clinical transplantation (01.07.2011)
Published in Clinical transplantation (01.07.2011)
Get full text
Journal Article
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Cree, Bruce A C, Bennett, Jeffrey L, Kim, Ho Jin, Weinshenker, Brian G, Pittock, Sean J, Wingerchuk, Dean M, Fujihara, Kazuo, Paul, Friedemann, Cutter, Gary R, Marignier, Romain, Green, Ari J, Aktas, Orhan, Hartung, Hans-Peter, Lublin, Fred D, Drappa, Jorn, Barron, Gerard, Madani, Soraya, Ratchford, John N, She, Dewei, Cimbora, Daniel, Katz, Eliezer
Published in The Lancet (British edition) (12.10.2019)
Published in The Lancet (British edition) (12.10.2019)
Get full text
Journal Article
Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis
Yan, Li, Kimko, Holly, Wang, Bing, Cimbora, Daniel, Katz, Eliezer, Rees, William A.
Published in Clinical pharmacokinetics (01.03.2022)
Published in Clinical pharmacokinetics (01.03.2022)
Get full text
Journal Article
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
Agius, Mark A, Klodowska-Duda, Gabriela, Maciejowski, Maciej, Potemkowski, Andrzej, Li, Jing, Patra, Kaushik, Wesley, Jacob, Madani, Soraya, Barron, Gerard, Katz, Eliezer, Flor, Armando
Published in Multiple sclerosis (01.02.2019)
Published in Multiple sclerosis (01.02.2019)
Get full text
Journal Article
Pharmacodynamic modelling and exposure–response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders
Yan, Li, Wang, Bing, She, Dewei, Mitchell, Ben, Criste, Ryan, Cimbora, Daniel, Katz, Eliezer, Rees, William A.
Published in British journal of clinical pharmacology (01.08.2022)
Published in British journal of clinical pharmacology (01.08.2022)
Get full text
Journal Article
Enhancing Kidney Transplantation and the Role of Xenografts: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Adams, Andrew B., Blumberg, Emily A., Gill, John S., Katz, Eliezer, Kawai, Tatsuo, Schold, Jesse D., Sykes, Megan, Tector, Alfred, Sachs, David H.
Published in American journal of kidney diseases (01.07.2024)
Published in American journal of kidney diseases (01.07.2024)
Get full text
Journal Article
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study
Schiopu, Elena, Chatterjee, Soumya, Hsu, Vivien, Flor, Armando, Cimbora, Daniel, Patra, Kaushik, Yao, Wenliang, Li, Jing, Streicher, Katie, McKeever, Kathleen, White, Barbara, Katz, Eliezer, Drappa, Jorn, Sweeny, Sarah, Herbst, Ronald
Published in Arthritis research & therapy (07.06.2016)
Published in Arthritis research & therapy (07.06.2016)
Get full text
Journal Article
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder
Aktas, Orhan, Hartung, Hans-Peter, Smith, Michael A, Rees, William A, Fujihara, Kazuo, Paul, Friedemann, Marignier, Romain, Bennett, Jeffrey L, Kim, Ho Jin, Weinshenker, Brian G, Pittock, Sean J, Wingerchuk, Dean M, Cutter, Gary, She, Dewei, Gunsior, Michele, Cimbora, Daniel, Katz, Eliezer, Cree, Bruce A
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2023)
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2023)
Get full text
Journal Article
American Society of Transplant Surgeons-American Society of Transplantation report of FDA meeting on regulatory expectations for xenotransplantation products
Adams, Andrew, Cendales, Linda C., Cooper, David K.C., Cozzi, Emanuele, Gill, John, Judd, Eric, Katz, Eliezer, Kirk, Allan D., Fishman, Jay A., Reese, Peter P., Wall, Anji, Markmann, James F.
Published in American journal of transplantation (01.09.2023)
Published in American journal of transplantation (01.09.2023)
Get full text
Journal Article